Fulgent Genetics to Acquire Bako Diagnostics Assets and StrataDx for $55.5 Million

Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...
Le Lézard

Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA

Natera, Inc. , a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with ...
Orange County Business Journal

Helio Announces Partnership with National Clinic

Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...
Le Lézard

2026 MASH-TAG Oral Presentation: HepQuant DuO® Reveals Functional and Physiological Heterogeneity to Support Enhanced Clinical Trial Design

HepQuant, a leader in developing noninvasive, blood-based, quantitative testing to assess liver health, presented oral and poster data findings at the 2026-MASH-TAG conference January 8-10, 2026, Park ...
PharmiWeb

SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer

CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...
PharmiWeb

NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue

Anticipates preliminary unaudited fourth quarter 2025 revenue of approximately $190 million; full-year 2025 revenue of $727 ...